Replimune Group Balance Sheet Health
Financial Health criteria checks 5/6
Replimune Group has a total shareholder equity of $381.5M and total debt of $45.6M, which brings its debt-to-equity ratio to 11.9%. Its total assets and total liabilities are $498.2M and $116.7M respectively.
Key information
11.9%
Debt to equity ratio
US$45.57m
Debt
| Interest coverage ratio | n/a |
| Cash | US$432.06m |
| Equity | US$381.46m |
| Total liabilities | US$116.74m |
| Total assets | US$498.20m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7R8's short term assets ($442.6M) exceed its short term liabilities ($43.8M).
Long Term Liabilities: 7R8's short term assets ($442.6M) exceed its long term liabilities ($73.0M).
Debt to Equity History and Analysis
Debt Level: 7R8 has more cash than its total debt.
Reducing Debt: 7R8's debt to equity ratio has increased from 8% to 11.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7R8 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 7R8 has sufficient cash runway for 2.1 years if free cash flow continues to reduce at historical rates of 30% each year.